Skip to main content

Pine Bark Extract

Scientific Name(s): Pinus pinaster Aiton., Pinus radiata
Common Name(s): Enzogenol, Maritime pine, Maritime pine extract, Monterey pine extract, Pycnogenol

Medically reviewed by Drugs.com. Last updated on Dec 19, 2022.

Clinical Overview

Use

Pine bark extract demonstrates antioxidant and anti-inflammatory actions and has been studied for a wide range of clinical conditions, including asthma, attention-deficit/hyperactivity disorder (ADHD), chronic venous insufficiency, cardiovascular conditions, diabetes, and erectile dysfunction. However, many clinical trials are methodologically weak, making it difficult to support the use of pine bark extract for any condition.

Dosing

In clinical trials, Pycnogenol dosages ranged from 20 to 360 mg (or were weight based), with the most common duration of use being 2 to 3 weeks; however, longer-term use has been described:

Contraindications

There are no known contraindications to pine bark extract use.

Pregnancy/Lactation

Information regarding safety and efficacy during pregnancy and lactation is lacking.

Interactions

None well documented.

Adverse Reactions

Pine bark extract is generally well tolerated, with occasional minor gastric discomfort, dizziness, nausea, and headache.

Toxicology

Pine bark extract is generally recognized as safe (GRAS) based on data from animal studies and clinical trials; however, few studies have evaluated safety as a primary outcome.

Scientific Family

Botany

P. pinaster Aiton (previously termed Prunus maritima Mill.) and P. radiata are medium-sized pines growing up to 30 m in height with bright red-brown, deeply fissured bark. They have stout needles occurring in clusters and produce oval cones 10 to 20 cm in length. The pine bark tree is native to the western and southwestern Mediterranean regions but has rapidly naturalized to other countries, including the United States, England, South Africa, and Australia. The largest man-made forest in the world, the 900,000 hectare Les Landes on the Atlantic coast of southwestern France, is populated almost entirely by P. pinaster.Maimoona 2011, USDA 2019

History

In 1535, a French explorer is reputed to have used tea made from the bark of the pine bark tree to treat scurvy among his sailors when his ship became icebound. The extract has been used for anemia, inflammation, and cardiovascular conditions. Pine bark has been used as a food source in emergencies. Commercial products of pine bark extract (eg, Pycnogenol) are available in health food stores and pharmacies in the United States, as well as from online sources.D'Andrea 2010, Duke 2002, Frevel 2012, Maimoona 2011

Chemistry

Pine bark extract is composed of 80% to 85% proanthocyanidins, the monomers catechin and taxifolin (5%), and phenolic acids, including derivatives of benzoic and cinnamic acids (2% to 4%). Depending on the extraction process and the source Pinus species used (P. radiata or P. pinaster), the exact composition will vary. Geographical and seasonal variation is also expected. Pine bark is boiled with saturated sodium chloride, cooled, and extracted with ethyl acetate. After concentration, the solution is precipitated with chloroform. This process is repeated several times to remove condensed tannins. In some studies, the extracted compounds are designated procyanidiol oligomers. The phenolic acids are derivatives of benzoic and cinnamic acids. As with pine bark extract, grape seed extract also contains oligomeric proanthocyanidins (OPCs); confusion has arisen when grape seed extract was marketed as containing "Pycnogenol," the proprietary name used for OPCs specifically derived from pine bark. Pine bark extract is included in the United States Pharmacopeia.D'Andrea 2010, Duke 2002, Frevel 2012, Maimoona 2011

Uses and Pharmacology

The quality of many published clinical studies has been limited by small sample sizes or the use of nonrandomized or open-label designs. Many studies have been conducted by a small pool of researchers, some being industry sponsored. Insufficient evidence exists supporting the use of pine bark extracts for any chronic condition. Findings from ongoing clinical trials are anticipated.(D'Andrea 2010, Maimoona 2011, Schoonees 2012)

Antioxidant properties of pine bark extracts have been well described in laboratory studies and are considered to be responsible for the majority of clinical effects.(D'Andrea 2010, Frevel 2012, Maimoona 2011) However, clinical studies evaluating changes in antioxidant status after pine bark extract administration have produced equivocal results.(Devaraj 2002, Dvořáková 2010, Silliman 2003)

Antibacterial activity

Animal data

In a murine model of periodontitis, pine bark extract as part of the diet exerted antibacterial activity against Porphyromonas gingivalis.(Sugimoto 2015)

Antidepressant-induced sexual dysfunction

Clinical data

In a clinical study involving men and women with antidepressant-induced sexual dysfunction, the effects of pine bark extract 50 mg/day for 4 months in combination with escitalopram were compared with escitalopram alone. The combination attenuated sexual dysfunction after 1 month of treatment and continued until the last visit.(Smetanka 2019)

Anti-inflammatory/Osteoarthritic effects

Animal and in vitro data

In a murine model of ischemia/reperfusion-induced injury, rats treated with pine bark extract (Pycnogenol) demonstrated less cortex damage and edema compared to the control group. Pycnogenol also significantly reduced interleukin (IL)-1beta and tumor necrosis factor alpha levels compared with the control group (P<0.001).(Ozoner 2019)

Clinical data

In a clinical study of patients with severe osteoarthritis scheduled to undergo knee arthroplasty, effects of pine bark extract 100 mg twice daily or placebo for 3 weeks prior to the procedure were assessed. Patients receiving pine bark extract had a reduction in matrix metallopeptidase-3 (MMP-3), MMP-13, and IL-1beta levels (markers of cartilage degradation).(Jessberger 2017) Evidence also suggests that polyphenols of pine bark extract distribute into synovial fluid.(Mülek 2017)

Antiviral effects

In vitro data

In one study, pine bark extract combined with ribavirin, interferon, and telaprevir increased hepatitis C virus antiviral activity, either synergistically or additively.(Ezzikouri 2016)

Bone effects

Animal and in vitro data

In a study of ovariectomized rats, pine bark extract 40 mg/kg given for 9 weeks increased bone mineral density, decreased biomarkers of bone resorption, and restored impaired trabecular microarchitecture.(Huang 2015) In a murine model of periodontitis, pine bark extract as part of the diet inhibited osteoclast differentiation.(Sugimoto 2015)

Clinical data

Administration of 250 mg/day of French maritime pine bark extract (Oligopin) for 12 weeks significantly improved bone remodelling markers compared to placebo (P=0.006) in postmenopausal women with osteopenia in a double-blind, randomized, controlled trial (n=44). No between-group differences were observed in calcium, phosphorus, magnesium, vitamin D, or parathyroid hormone levels.(Panahande 2019)

Cardiovascular effects

Animal and in vitro data

Studies in spontaneously hypertensive rats suggest a protective effect on microvasculature by pine bark extract, thought to be due to its antioxidant effects. Small decreases in systolic blood pressure were also observed.(Rezzani 2010) In a study of diabetic rats, cardiomyopathy was reduced by pine bark extract; the reduction was considered to be due to antioxidant activity but also possibly due to improved cardiac energy metabolism via observed lowered plasma glucose.(Klimas 2010) In a murine model of atherosclerosis, 12-week administration of pine bark extract was associated with a reduction in plaque areas as well as a reduction in lipids in the plaques. Additionally, serum lipid levels of total cholesterol, triglycerides, and low-density lipoprotein (LDL) were decreased, and high-density lipoprotein (HDL) was increased with pine bark extract treatment.(Luo 2015)

Clinical data

Changes in markers of oxidative stress in cardiovascular disease have been demonstrated in small clinical trials of pine bark extract.(Enseleit 2012, Nishioka 2007, Schoonees 2012, Young 2006)

A meta-analysis of 5 controlled studies (N=442) published between 2003 and 2012 included healthy volunteers as well as patients with hypertension, stable coronary artery disease, type 2 diabetes and hypertension, erectile dysfunction, elderly age, and perimenopausal status receiving the standardized maritime pine bark extract Pycnogenol (dosed at 120 to 200 mg/day for durations of 2 to 24 weeks). Lipid parameters (ie, total cholesterol, HDL, triglycerides), excluding LDL, were not affected by supplementation with Pycnogenol. A significant dose-effect association was found for effects on LDL (slope, −0.007; P=0.01). Limitations of the analysis included observed effect sizes too small to be clinically relevant, lack of data on concomitant lipid-lowering drugs, and uncontrolled dietary measures.(Sahebkar 2014)

In another systematic review and meta-analysis including 14 trials of 1,065 patients, pine bark extract (dosage range, 60 to 340 mg daily) significantly increased HDL (3.27 mg/dL; 95% CI, 0.19 to 6.36; P=0.038). However, there were no effects on other cholesterol parameters (total cholesterol, triacylglycerol, and LDL).(Hadi 2019)

Pine bark extract supplementation significantly impacted C-reactive protein levels (−1.22 mg/dL; 95% CI, −2.43 to −0.003; I2=99%; P<0.001) in another systematic review and meta-analysis.(Nikpayam 2018)

Cancer

Animal and in vitro data

Pine bark extract reduced apoptosis in human oral squamous cell carcinoma HSC-3 cells, MC-3 human mucoepidermoid carcinoma (MEC) cells, and HT 1080 fibrosarcoma cells.(Harati 2015, Yang 2014, Yang 2016) Additionally, pine bark extract suppressed neoplastic transformation in HSC-3 cells and decreased cell viability in MEC cells.(Yang 2014, Yang 2016)

CNS/Cognitive effects

Animal and in vitro data

In a murine model of Alzheimer disease, pine bark extract improved spatial memory in the pre-onset (ie, just before the development of plaques) treatment paradigm group. In both the pre-onset and post-onset (ie, after the appearance of beta-amyloid plaques) paradigm treatment groups, pine bark extract reduced plaque number (ie, decreased the number of small plaques in the pre-onset group, and reduced the number of large plaques in the post-onset group) but did not change the average plaque size.(Paarmann 2019) In a murine model of pentylenetetrazole-induced epilepsy, pine bark extract increased latency, decreased duration, and reduced frequency of seizures in a dose-dependent manner compared with the control group.(Goel 2019)

Clinical data

Pine bark extract resulted in enhanced concentration and reduced hyperactivity after 1 month of therapy in a study of children with ADHD. Visual-motor coordination was also improved. Effects might be attributed to reductions in catecholamine levels, such as dopamine, epinephrine, and norepinephrine, as well as stimulation of endothelial nitric oxide synthase.(Verlaet 2018)

In a registry study of 87 patients with mild cognitive impairment (Mini-Mental State Examination [MMSE] score of 18 to 23), pine bark extract 150 mg/day for 8 weeks significantly improved MMSE scores from baseline (21.64±1.5) to 8 weeks (25.64±1.4; P<0.05). This effect was not seen in those receiving standard care. The median increase associated with pine bark extract was 18% compared with 2.48% in the standard care group (P<0.05).(Hosoi 2018)

Dermatological effects

Clinical data

A review article describes several small studies regarding pine bark extract's potential beneficial dermatological effects. It is believed to provide ultraviolet (UV) protection, decrease skin hyperpigmentation, and improve the skin barrier. In one study, pine bark extract (1.1 mg/kg or 1.66 mg/kg) given orally for 4 to 8 weeks reduced UV-induced erythema in fair-skinned individuals. Additionally, pine bark extract 75 mg/day given orally for 1 month improved parameters measuring melasma in a study of 30 Chinese females. Lastly, when combined with vitamins and minerals, pine bark extract improved elasticity of the skin in women.(Grether-Beck 2016)

Diabetes

Animal and in vitro data

In vitro studies suggest pine bark extract exhibits a number of beneficial effects, including inhibition of lipid accumulation in adipocytes, stimulation of lipolysis, and increased glucose uptake.(Hasegawa 2000, Lee 2010, Lee 2012) Pine bark extract may inhibit alpha-glucosidase.(Gulati 2015)

In rodent studies, pine bark extract showed antioxidant effects and improved insulin resistance and hyperglycemia.(Aydin 2019, Bang 2014, Berryman 2004) Additionally, pine bark extract improved oxidative stress, lipid profiles, liver function markers, and DNA damage in hyperglycemic rats.(Aydin 2019)

Clinical data

Limited, methodologically weak clinical trials have been conducted in patients with type 2 diabetes.(Schoonees 2012) Doses of pine bark extract 150 mg daily have been used in these studies with no apparent serious adverse effects; more robust clinical studies are needed. A double-blind, randomized, placebo-controlled study conducted in 46 adults with type 2 diabetes and evidence of microalbuminuria reported significant decreases in mean adjusted glycated hemoglobin (HbA1c) (−1.17%; P<0.001), total cholesterol (−20.5 mg/dL; P=0.03), vascular cell adhesion molecule 1 (−9.16; P<0.001), and urinary albumin:creatinine ratio (−16.35; P<0.001) with supplementation of 100 mg pine bark extract daily for 8 weeks compared to placebo. However, no difference between groups was observed in fasting blood glucose, insulin, insulin resistance, triglycerides, LDL, or HDL. The supplement was well tolerated with no adverse events observed.(Navval-Esfahlan 2021)

Drug-induced toxicity

Animal and in vitro data

Rat models have demonstrated pine bark extract's ability to protect against cisplatin-induced ototoxicity and acute kidney injury.(Eryilmaz 2016, Lee 2017) Additionally, pine bark extract exerted antioxidant and hepatoprotective effects in a study of rats with acetaminophen-induced hepatotoxicity.(Rašković 2019)

Female reproductive disorders

Clinical data

In a clinical study of 58 women with endometriosis, pine bark extract 60 mg/day for 48 weeks improved symptoms of pelvic pain, pelvic tenderness, menstrual pain, and induration without impacting estrogen levels or menstrual cycles. However, CA-125 levels decreased.(Kohama 2007) In another study, women receiving pine bark extract with a low-dose oral contraceptive had lower pain scores for dysmenorrhea compared to women receiving only the low-dose oral contraceptive.(Maia 2014)

Male reproductive disorders

The beneficial effects of pine bark extract in erectile dysfunction are believed to be attributed to the activation of endothelial nitric oxide synthase, which leads to enhanced nitric oxide production and vasodilation.(Chang 2019)

Animal and in vitro data

In a murine study, pine bark extract 40 mg/kg decreased serum and prostate dihydrotestosterone concentrations and reduced the weight of the prostate. Pine bark extract also resulted in thinner epithelial cells in the prostate gland.(Ko 2018)

Clinical data

In a clinical study of 75 men with signs and symptoms of benign prostatic hyperplasia, Pycnogenol 50 mg 3 times daily for 60 days significantly improved emptying, frequency, intermittency, urgency, weak flow, straining, and nocturia compared with a standard management group and a group receiving 5-alpha reductase inhibitor therapy (P<0.05 for both comparisons).(Ledda 2018)

A meta-analysis showed that the combination of pine bark extract and arginine improved erectile dysfunction.(Chang Rhim 2019)

Respiratory effects

Animal and in vitro data

In an in vitro study of ovalbumin-induced allergic asthma, pine bark extract decreased nitric oxide production and IL-1beta and IL-6 levels. In the in vivo arm of the study, ovalbumin-sensitized mice showed a decrease in the number of inflammatory cells and in airway hyperreactivity.(Shin 2013) In a murine model of chronic obstructive pulmonary disease, pine bark extract decreased the inflammatory cells caused by cigarette smoke and lipopolysaccharide exposure in bronchoalveolar lavage fluid, and inhibited collagen deposition in the lungs.(Ko 2017, Shin 2016)

Clinical data

Limited small studies evaluating Pycnogenol use in children and adults with asthma have indicated benefit.(Clark 2010, Schoonees 2012)

Based on data from 4,521 healthy participants enrolled in 20 randomized controlled trials (including 1 study with pycnogenol), meta-analyses demonstrated that flavonoid-containing supplements were safe and effective in preventing acute respiratory tract infections (ARTIs) compared to controls with a relative risk (RR) of 0.81 (95% confidence interval [CI] 0.74 to 0.89; P<0.001) and low heterogeneity. A reduction in mean ARTI sick days was also observed with the supplements; however, heterogeneity was significant (weighted mean difference [WMD], −0.56; 95% CI, −1.04 to −0.08; P=0.021). In subgroup analysis, significance in mean ARTI sick days was retained with flavonoid mixtures (as seen with pycnogenol products) but not with use of single flavonoids (ie, quercetin, catechin). Additionally, the pycnogenol study reported faster regression of all symptoms compared to controls (P<0.05). Pooled results from 16 of the trials indicated that adverse reactions were not increased in the flavonoid supplement groups compared to controls.(Yao 2022)

Venous insufficiency/Varicose veins

In a review of natural products used in the treatment of chronic venous insufficiency, pine bark extract exerted antioxidant, anti-inflammatory, and vasoactive effects. It reduced passive dilatation and stretching, giving the venous wall enhanced elasticity and promoting the ability of the vein to recover following stress.(Lichota 2019)

Clinical data

In healthy women after their second pregnancy, the effects of pine bark extract (100 mg/day for 12 months) on varicose veins were assessed. At 3 and 6 months, the number of varicose veins was lower. At 6 months, fewer patients in the group receiving pine bark extract (3.2%) experienced edema compared to the control group (13.3%). Cramps and the presence of spider veins were reduced in those receiving pine bark extract, and there was less of a need for interventions for varicose veins. Reevaluation at 12 months showed that variations in varicose veins, spider veins, and symptoms had not changed from the 6-month follow-up.(Belcaro 2017)

Dosing

In clinical trials, Pycnogenol dosages ranged from 20 to 360 mg (or were weight based). The American Botanical Council states the most common duration of use in clinical trials was 2 to 3 weeksABC 2019; however, longer-term use has been described.

Pregnancy / Lactation

Information regarding safety and efficacy during pregnancy and lactation is lacking. Pine bark extract at a dose of 30 mg/day has been studied in a small clinical trial for pain in the third trimester of pregnancy and did not result in any adverse effects; however, this should not be regarded as evidence of safety in pregnancy.Kohama 2006

Interactions

None well documented.

Adverse Reactions

Pine bark extract is generally well tolerated, with occasional minor GI discomfort, dizziness, nausea, and headache reported. GI discomfort may be minimized by taking the product with or after meals. In women using Pycnogenol for dysmenorrhea or endometriosis, acne and dysfunctional uterine bleeding have been reported; additionally, diarrhea has been reported in those with dysmenorrhea and epigastric pain in those with endometriosis.ABC 2019

Toxicology

Pine bark extract is GRAS based on data from animal studies and clinical trials; however, few studies have evaluated safety as a primary outcome.D'Andrea 2010, Dvořáková 2010, Maimoona 2011, USDA 2019 P. radiata extract was nonmutagenic in the Ames test.Frevel 2012 Pine bark is a member of the Pinaceae (Pine) family; consumption of pine needles has been associated with abortion in cattle.Pütter 1999

Index Terms

References

Disclaimer

This information relates to an herbal, vitamin, mineral or other dietary supplement. This product has not been reviewed by the FDA to determine whether it is safe or effective and is not subject to the quality standards and safety information collection standards that are applicable to most prescription drugs. This information should not be used to decide whether or not to take this product. This information does not endorse this product as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this product. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from your health care provider. You should talk with your health care provider for complete information about the risks and benefits of using this product.

This product may adversely interact with certain health and medical conditions, other prescription and over-the-counter drugs, foods, or other dietary supplements. This product may be unsafe when used before surgery or other medical procedures. It is important to fully inform your doctor about the herbal, vitamins, mineral or any other supplements you are taking before any kind of surgery or medical procedure. With the exception of certain products that are generally recognized as safe in normal quantities, including use of folic acid and prenatal vitamins during pregnancy, this product has not been sufficiently studied to determine whether it is safe to use during pregnancy or nursing or by persons younger than 2 years of age.

More about maritime pine

Related treatment guides

American Botanical Council proprietary botanical ingredient scientific and clinical monograph for Pycnogenol. American Botanical Council website. http://abc.herbalgram.org/site/DocServer/Pycnog_FullMono120809_LOW.pdf?docID=1741. Accessed May 23, 2019.
Aydin S, Bacanli M, Anlar HG, et al. Preventive role of Pycnogenol against the hyperglycemia-induced oxidative stress and DNA damage in diabetic rats. Food Chem Toxicol. 2019;124:54-63.30465898
Bang CY, Choung SY. Enzogenol improves diabetes-related metabolic change in C57BL/KsJ-db/db mice, a model of type 2 diabetes mellitus. J Pharm Pharmacol. 2014;66(6):875-885.24611864
Belcaro G, Dugall M, Luzzi R, Ippolito E, Cesarone MR. Postpartum varicose veins: supplementation with Pycnogenol or elastic compression—a 12-month follow-up. Int J Angiol. 2017;26(1):12-19.28255210
Berryman AM, Maritim AC, Sanders RA, Watkins JB III. Influence of treatment of diabetic rats with combinations of Pycnogenol, beta-carotene, and alpha-lipoic acid on parameters of oxidative stress. J Biochem Mol Toxicol. 2004;18(6):345-352.15674846
Chang Rhim H, Kim MS, Park YJ, et al. The potential role of arginine supplements on erectile dysfunction: a systemic review and meta-analysis. J Sex Med. 2019;16(2):223-234.30770070
Clark CE, Arnold E, Lasserson TJ, Wu T. Herbal interventions for chronic asthma in adults and children: a systematic review and meta-analysis. Prim Care Resp J. 2010;19(4):307-314.20640388
D'Andrea G. Pycnogenol: a blend of procyanidins with multifaceted therapeutic applications? Fitoterapia. 2010;81(7):724-736.20598812
Devaraj S, Vega-López S, Kaul N, Schönlau F, Rohdewald P, Jialal I. Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile. Lipids. 2002;37(10):931-934.12530550
Duke J, Bogenschutz-Godwin M, duCellier J, Duke P. Handbook of medicinal herbs. 2nd ed. ed. Boca Raton, FL: CRC Press; 2002.
Dvořáková M, Paduchová Z, Muchová J, Duračková Z, Collins AR. How does Pycnogenol influence oxidative damage to DNA and its repair ability in elderly people? Prague Med Rep. 2010;111(4):263-271.21189165
Enseleit F, Sudano I, Periat D, et al. Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study. Eur Heart J. 2012;33(13):1589-1597.22240497
Eryilmaz A, Kilyatkin N, Demirci B, et al. Protective effects of Pycnogenol on cisplatin-induced ototoxicity in rats. Pharm Biol. 2016;54(11):2777-2781.27158843
Ezzikouri S, Jadid FZ, Hamdi S, Wakrim L, Tsukiyama-Kohara K, Benjelloun S. Supplementing conventional treatment with Pycnogenol may improve hepatitis C virus-associated type 2 diabetes. A mini review. J Clin Transl Hepatol. 2016;4(3):228-233.27777890
Frevel MA, Pipingas A, Grigsby WJ, Frampton CM, Gilchrist NL. Production, composition and toxicology studies of EnzogenolPinus radiata bark extract. Food Chem Toxicol. 2012;50(12):4316-4324.22982471
Goel R, Saxena P. Pycnogenol protects against pentylenetetrazole-induced oxidative stress and seizures in mice. Curr Clin Pharmacol. 2019;14(1):68-75.30465512
Grether-Beck S, Marini A, Jaenicke T, Krutmann J. French maritime pine bark extract (Pycnogenol) effects on human skin: clinical and molecular evidence. Skin Pharmacol Physiol. 2016;29(1):13-17.26492562
Gulati OP. Pycnogenol in metabolic syndrome and related disorders. Phytother Res. 2015;29(7):949-968.25931421
Hadi A, Pourmasoumi M, Mohammadi H, Javaheri A, Rouhani MH. The impact of Pycnogenol supplementation on plasma lipids in humans: a systematic review and meta-analysis of clinical trials. Phytother Res. 2019;33(2):276-287.30456865
Harati K, Slodnik P, Chromik AM, et al. Pro-apoptotic effects of Pycnogenol on HT1080 human fibrosarcoma cells. Int J Oncol. 2015;46(4):1629-1636.25625225
Hasegawa N. Inhibition of lipogenesis by Pycnogenol. Phytother Res. 2000;14(6):472-473.10960907
Hosoi M, Belcaro G, Saggino A, Luzzi R, Dugall M, Feragalli B. Pycnogenol supplementation in minimal cognitive dysfunction. J Neurosurg Sci. 2018;62(3):279-284.29754480
Huang G, Wu J, Wang S, et al. Pycnogenol treatment inhibits bone mineral density loss and trabecular deterioration in ovariectomized rats. Int J Clin Exp Med. 2015;8(7):10893-10901.26379883
Jessberger S, Högger P, Genest F, Salter DM, Seefried L. Cellular pharmacodynamic effects of Pycnogenol in patients with severe osteoarthritis: a randomized controlled pilot study. BMC Complement Altern Med. 2017;17(1):537.29246219
Klimas J, Kmecova J, Jankyova S, et al. Pycnogenol improves left ventricular function in streptozotocin-induced diabetic cardiomyopathy in rats. Phytother Res. 2010;24(7):969-974.19957251
Ko JW, Park SW, Shin NR, et al. Inhibitory effects of Pycnogenol, a pine bark extract, in a rat model of testosterone propionate-induced benign prostatic hyperplasia. Lab Anim Res. 2018;34(3):111-117.30310407
Ko JW, Shin NR, Park SH, et al. Pine bark extract (Pycnogenol) suppresses cigarette smoke-induced fibrotic response via transforming growth factor-β1/Smad family member 2/3 signaling. Lab Anim Res. 2017;33(2):76-83.28747971
Kohama T, Herai K, Inoue M. Effect of French maritime pine bark extract on endometriosis as compared with leuprorelin acetate. J Reprod Med. 2007;52(8):703-708.17879831
Kohama T, Inoue M. Pycnogenol alleviates pain associated with pregnancy. Phytother Res. 2006;20(3):232-234.16521117
Ledda A, Belcaro G, Feragalli B, et al. Benign prostatic hypertrophy: Pycnogenol supplementation improves prostate symptoms and residual bladder volume. Minerva Med. 2018;109(4):280-284.29947491
Lee HH, Kim KJ, Lee OH, Lee BY. Effect of Pycnogenol on glucose transport in mature 3T3-L1 adipocytes. Phytother Res. 2010;24(8):1242-1249.20658573
Lee IC, Ko JW, Park SH, et al. Ameliorative effects of pine bark extract on cisplatin-induced acute kidney injury in rats. Ren Fail. 2017;39(1):363-371.28178874
Lee OH, Seo MJ, Choi HS, Lee BY. Pycnogenol inhibits lipid accumulation in 3T3-L1 adipocytes with the modulation of reactive oxygen species (ROS) production associated with antioxidant enzyme responses. Phytother Res. 2012;26(3):403-411.21796705
Lichota A, Gwozdzinski L, Gwozdzinski K. Therapeutic potential of natural compounds in inflammation and chronic venous insufficiency. Eur J Med Chem. 2019;176:68-91.31096120
Luo H, Wang J, Qiao C, Ma N, Liu D, Zhang W. Pycnogenol attenuates atherosclerosis by regulating lipid metabolism through the TLR4-NK-ĸB pathway. Exp Mol Med. 2015;47:e191.26492950
Maia H Jr, Haddad C, Casoy J. The effect of Pycnogenol on patients with dysmenorrhea using low-dose oral contraceptives. Int J Womens Health. 2014;6:1019-1022.25525393
Maimoona A, Naeem I, Saddiqe Z, Jameel K. A review on biological, nutraceutical and clinical aspects of French maritime pine bark extract. J Ethnopharmacol. 2011;133(2):261-277.21044675
Mülek M, Seefried L, GEnest F, Högger P. Distribution of constituents and metabolites of maritime pine bark extract (Pycnogenol) into serum, blood cells, and synovial fluid of patients with severe osteoarthritis: a randomized controlled trial. Nutrients. 2017;9(5).28452960
Navval-Esfahlan E, Rafraf M, Asghari S, Imani H, Asghari-Jafarabadi M, Karimi-Avval S. Effect of French maritime pine bark extract supplementation on metabolic status and serum vascular cell adhesion molecule-1 levels in patients with type 2 diabetes and microalbuminuria. Complement Ther Med. 2021;58:102689.33610726
Nikpayam O, Rouhani MH, Pourmasoumi M, Roshanravan N, Ghaedi E, Mohammadi H. The effect of Pycnogenol supplementation on plasma C-reactive protein concentration: a systematic review and meta-analysis. Clin Nutr Res. 2018;7(2):117-125.29713620
Nishioka K, Hidaka T, Nakamura S, et al. Pycnogenol, French maritime pine bark extract, augments endothelium-dependent vasodilation in humans. Hypertens Res. 2007;30(9):775-780.18037769
Ozoner B, Yuceli S, Aydin S, et al. Effects of Pycnogenol on ischemia/reperfusion-induced inflammatory and oxidative brain injury in rats. Neurosci Lett. 2019;704:169-175.30965107
Paarmann K, Prakash SR, Krohn M, et al. French maritime pine bark treatment decelerates plaque development and improves spatial memory in Alzheimer's disease mice. Phytomedicine. 2019;57:39-48.30668321
Panahande SB, Maghbooli Z, Hossein-nezhad A, et al. Effects of French maritime pine bark extract (Oligopin) supplementation on bone remodelling markers in postmenopausal osteopenic women: a randomized clinical trial. Phytother Res. 2019;33(4):1233-1240.30907034
Pinus Pinaster Aiton, Pinus radicata D. Don. USDA, NRCS. 2014. The PLANTS Database (http://plants.usda.gov,10 June 2019). National Plant Data Team, Greensboro, NC 27401-4901 USA. Accessed June 10, 2019.
Pütter M, Grotemeyer KH, Würthwein G, et al. Inhibition of smoking-induced platelet aggregation by aspirin and Pycnogenol. Thromb Res. 1999;95(4):155-161.10498385
Rašković A, Bukumirović N, Paut Kusturica M, et al. Hepatoprotective and antioxidant potential of Pycnogenol in acetaminophen-induced hepatotoxicity in rats. Phytother Res. 2019;33(3):631-639.30556209
Rezzani R, Porteri E, De Ciuceis C, et al. Effects of melatonin and Pycnogenol on small artery structure and function in spontaneously hypertensive rats. Hypertension. 2010;55(6):1373-1380.20421515
Sahebkar A. A systematic review and meta-analysis of the effects of Pycnogenol on plasma lipids. J Cardiovasc Pharmacol Ther. 2014;19(3):244-255.24346156
Schoonees A, Visser J, Musekiwa A, Volmink J. Pycnogenol (extract of French maritime pine bark) for the treatment of chronic disorders. Cochrane Database Syst Rev. 2012;4:CD008294.22513958
Shin IS, Shin NR, Jeon CM, et al. Inhibitory effects of Pycnogenol (French maritime pine bark extract) on airway inflammation in ovalbumin-induced allergic asthma. Food Chem Toxicol. 2013;62:681-686.24120901
Shin NR, Ryu HW, Ko JW, et al. A standardized bark extract of Pinus pinaster Aiton (Pycnogenol) attenuated chronic obstructive pulmonary disease via Erk-sp1 signaling pathway. J Ethnopharmacol. 2016;194:412-420.27725237
Silliman K, Parry J, Kirk LL, Prior RL. Pycnogenol does not impact the antioxidant or vitamin C status of healthy young adults. J Am Diet Assoc. 2003;103(1):67-72.12525796
Smetanka A, Stara V, Farsky I, Tonhajzerova I, Ondrejka I. Pycnogenol supplementation as an adjunct treatment for antidepressant-induced sexual dysfunction. Physiol Int. 2019;106(1):59-69.30888217
Sugimoto H, Watanabe K, Toyama T, et al. Inhibitory effects of French pine bark extract, Pycnogenol, on alveolar bone resorption and on the osteoclast differentiation. Phytother Res. 2015;29(2):251-259.25336411
Verlaet AA, Maasakkers CM, Hermans N, Savlkoul HF. Rationale for dietary antioxidant treatment of ADHD. Nutrients. 2018;10(4).29587355
Yang IH, Shin JA, Cho SD. Pycnogenol induces nuclear translocation of apoptosis-inducing factor and caspase-independent apoptosis in MC-3 human mucoepidermoid carcinoma cell line. J Cancer Prev. 2014;19(4):265-272.25574461
Yang IH, Shin JA, Kim LH, Kwon KH, Cho SD. The caspase 3-dependent apoptotic effect of Pycnogenol in human oral squamous cell carcinoma HSC-3 cells. J Clin Biochem Nutr. 2016;58(1):40-47.26798196
Yao J, Zhao J, Wen JR, et al. Flavonoid-containing supplements for preventing acute respiratory tract infections: A systematic review and meta-analysis of 20 randomized controlled trials. Complement Ther Med. 2022;70:102865. doi:10.1016/j.ctim.2022.10286535940344
Young JM, Shand BI, McGregor PM, Scott RS, Frampton CM. Comparative effects of enzogenol and vitamin C supplementation versus vitamin C alone on endothelial function and biochemical markers of oxidative stress and inflammation in chronic smokers. Free Radic Res. 2006;40(1):85-94.16298763

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Copyright © 2024 Wolters Kluwer Health